Literature DB >> 22183494

DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with dupuytren's disease: potential role for MMP and Wnt signaling pathway.

Barbara Shih1, May Tassabehji, James Stewart Watson, Ardeshir Bayat.   

Abstract

BACKGROUND: Dupuytren's disease is a common fibroproliferative disorder with an unknown etiology. Emerging evidence suggests a strong genetic component involved in the manifestation of the disease. This study aims to investigate the potential involvement of copy number variations in Dupuytren's disease pathogenesis.
METHODS: Array-based comparative genomic hybridization (NimbleGen Human CGH 2.1 M) was utilized to compare DNA from (1) nodules versus internal control (patient's blood; n = 4) and (2) nodules (n = 4) versus external control (commercial reference DNA pooled from 10 donors). Analysis was carried out using Nexus 5.1 (BioDiscovery, El Segundo, Calif.) with the inclusion of additional results from previously published array-based comparative genomic hybridization. Copy number variations were considered to be common in Dupuytren's disease if the overlap was statistically significant and they were present in the majority (75 to 87.5 percent when compared with controls) of Dupuytren's disease nodules. The copy number variations loci were also compared with recently published genome wide-association studies. Common copy number variations were further validated using quantitative polymerase chain reaction. DNA from 25 Dupuytren's disease cases and 30 external controls were used in the quantitative polymerase chain reaction validation. In addition, gene expression was compared between Dupuytren's disease nodules and internal controls (transverse palmar fascia; n = 7).
RESULTS: Five common copy number variations, on chromosome 17q12, 1p31.1, 20p13, 7p14.1, and 14q11.2, were identified by array-based comparative genomic hybridization. Significantly higher copy numbers of copy number variations at chromosome 7p14.1 and 14q11.2 in Dupuytren's disease were confirmed in quantitative polymerase chain reaction validation. Matrix metalloproteinase-14 and secreted frizzled-related protein 4 (near a polymorphism recently associated with Dupuytren's disease) were significantly up-regulated in nodules.
CONCLUSION: This study demonstrated an association between Dupuytren's disease and copy number variations at chromosomes 7p14.1 and 14q11.2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22183494     DOI: 10.1097/PRS.0b013e3182442343

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  SNPs previously associated with Dupuytren's disease replicated in a North American cohort.

Authors:  Eric R Anderson; Zhan Ye; Michael D Caldwell; James K Burmester
Journal:  Clin Med Res       Date:  2014-02-26

2.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

3.  Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.

Authors:  Rujue Jin; Weigang Zhu; Jiajun Xu; Jianhui Gu; Aidong Deng
Journal:  Gene Ther       Date:  2022-03-28       Impact factor: 5.250

4.  Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution.

Authors:  Lixian Chang; Zejia Cui; Deyang Shi; Yajing Chu; Bichen Wang; Yang Wan; Qiuyi Ma; Ranran Zhang; Haoyuan Li; Xuelian Cheng; Tao Cheng; Xiaofan Zhu; Cheng Li; Weiping Yuan
Journal:  Exp Hematol Oncol       Date:  2022-09-27

5.  A genome-wide study of de novo deletions identifies a candidate locus for non-syndromic isolated cleft lip/palate risk.

Authors:  Samuel G Younkin; Robert B Scharpf; Holger Schwender; Margaret M Parker; Alan F Scott; Mary L Marazita; Terri H Beaty; Ingo Ruczinski
Journal:  BMC Genet       Date:  2014-02-14       Impact factor: 2.797

6.  Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.

Authors:  Evert-Jan P M Ten Dam; Marike M van Beuge; Ruud A Bank; Paul M N Werker
Journal:  J Cell Commun Signal       Date:  2015-12-03       Impact factor: 5.782

7.  Evaluation of WNT Signaling Pathway Gene Variants WNT7B rs6519955, SFRP4 rs17171229 and RSPO2 rs611744 in Patients with Dupuytren's Contracture.

Authors:  Gediminas Samulėnas; Alina Smalinskienė; Rytis Rimdeika; Kęstutis Braziulis; Mantas Fomkinas; Rokas Paškevičius
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.